Visceral adipose tissue predicts risk for atherogenic dyslipidemia

Core needle biopsy proves sensitive for first-line thyroid nodule diagnosis

Cushing’s syndrome investigational drug receives patent

14 Dec 2015

The U.S. Patent and Trademark office recently granted a patent to Strongbridge Biopharma Plc for the company’s investigational drug COR-003 for the treatment of Cushing’s syndrome.

Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read